C M Bidwell & Associates LTD Castle Biosciences Inc Transaction History
C M Bidwell & Associates LTD
- $162 Million
- Q3 2024
A detailed history of C M Bidwell & Associates LTD transactions in Castle Biosciences Inc stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 2,600 shares of CSTL stock, worth $69,316. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,600
Previous 1,655
57.1%
Holding current value
$69,316
Previous $36,000
105.56%
% of portfolio
0.05%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding CSTL
# of Institutions
201Shares Held
24.5MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$81.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$48.7 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$46.6 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$33.6 Million0.61% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$33.5 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $701M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...